- increased bone mineral density / IMPC
- decreased circulating LDL cholesterol level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased leukocyte cell number / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating creatinine level / IMPC
- increased blood urea nitrogen level / IMPC
- decreased total body fat amount / IMPC
- increased circulating fructosamine level / IMPC
- hyperplasia / IMPC
- neoplasm / IMPC
- lymphoid neoplasms / IMPC
C57BL/6NTac-Setd1atm1a(EUCOMM)Wtsi/WtsiCnrm
Status | Available to order |
EMMA ID | EM:06857 |
International strain name | C57BL/6NTac-Setd1atm1a(EUCOMM)Wtsi/WtsiCnrm |
Alternative name | EPD0027_4_H10 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Setd1atm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Setd1a |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0027_4_H10. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- lymphoid neoplasms / IMPC
- hyperplasia / IMPC
- increased blood urea nitrogen level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased leukocyte cell number / IMPC
- decreased circulating LDL cholesterol level / IMPC
- increased circulating fructosamine level / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating creatinine level / IMPC
- decreased total body fat amount / IMPC
- increased bone mineral density / IMPC
- neoplasm / IMPC
MGI phenotypes (allele matching)
- increased bone mineral density / MGI
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- decreased leukocyte cell number / MGI
- decreased circulating alanine transaminase level / MGI
- decreased circulating alkaline phosphatase level / MGI
- decreased rib number / MGI
- decreased circulating cholesterol level / MGI
- decreased total body fat amount / MGI
MGI phenotypes (gene matching)
- increased bone mineral density / MGI
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- decreased leukocyte cell number / MGI
- failure to gastrulate / MGI
- decreased circulating alanine transaminase level / MGI
- decreased circulating alkaline phosphatase level / MGI
- decreased rib number / MGI
- decreased circulating cholesterol level / MGI
- cellular phenotype / MGI
- abnormal cell physiology / MGI
- abnormal DNA methylation / MGI
- decreased total body fat amount / MGI
- embryonic lethality between implantation and somite formation, complete penetrance / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).